GLPL (2)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Goldline Pharmaceutical Limited's equity shares will be listed on BSE SME platform effective May 19, 2026, in the 'MT' Group under … | |||||||||||||||
Goldline Pharmaceutical Limited's equity shares will be listed on BSE SME platform effective May 19, 2026, in the 'MT' Group under Trade-for-Trade segment for 10 trading days.
| |||||||||||||||
BSE notifies trading members that equity shares of Goldline Pharmaceutical Limited (scrip code 544759, symbol GLPL) will be listed on the … | |||||||||||||||
BSE notifies trading members that equity shares of Goldline Pharmaceutical Limited (scrip code 544759, symbol GLPL) will be listed on the SME segment. The date of listing and security details will be communicated via a separate notice.
| |||||||||||||||